201 related articles for article (PubMed ID: 27456844)
21. Exploring the Feasibility of Comprehensive Uncertainty Assessment in Health Economic Modeling: A Case Study.
Petersohn S; Grimm SE; Ramaekers BLT; Ten Cate-Hoek AJ; Joore MA
Value Health; 2021 Jul; 24(7):983-994. PubMed ID: 34243842
[TBL] [Abstract][Full Text] [Related]
22. Use (and abuse) of expert elicitation in support of decision making for public policy.
Morgan MG
Proc Natl Acad Sci U S A; 2014 May; 111(20):7176-84. PubMed ID: 24821779
[TBL] [Abstract][Full Text] [Related]
23. Expert judgement in a risk assessment model for Salmonella spp. in pork: the performance of different weighting schemes.
Boone I; Van der Stede Y; Bollaerts K; Messens W; Vose D; Daube G; Aerts M; Mintiens K
Prev Vet Med; 2009 Nov; 92(3):224-34. PubMed ID: 19782415
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
Ramsay C; Pickard R; Robertson C; Close A; Vale L; Armstrong N; Barocas DA; Eden CG; Fraser C; Gurung T; Jenkinson D; Jia X; Lam TB; Mowatt G; Neal DE; Robinson MC; Royle J; Rushton SP; Sharma P; Shirley MD; Soomro N
Health Technol Assess; 2012; 16(41):1-313. PubMed ID: 23127367
[TBL] [Abstract][Full Text] [Related]
26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
27. The use of expert elicitation in environmental health impact assessment: a seven step procedure.
Knol AB; Slottje P; van der Sluijs JP; Lebret E
Environ Health; 2010 Apr; 9():19. PubMed ID: 20420657
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
29. The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.
Cadham CJ; Knoll M; Sánchez-Romero LM; Cummings KM; Douglas CE; Liber A; Mendez D; Meza R; Mistry R; Sertkaya A; Travis N; Levy DT
Med Decis Making; 2022 Jul; 42(5):684-703. PubMed ID: 34694168
[TBL] [Abstract][Full Text] [Related]
30. The use of probabilistic decision models in technology assessment : the case of total hip replacement.
Briggs A; Sculpher M; Dawson J; Fitzpatrick R; Murray D; Malchau H
Appl Health Econ Health Policy; 2004; 3(2):79-89. PubMed ID: 15702945
[TBL] [Abstract][Full Text] [Related]
31. An expert on every street corner? Methods for eliciting distributions in geographically dispersed opinion pools.
Sperber D; Mortimer D; Lorgelly P; Berlowitz D
Value Health; 2013; 16(2):434-7. PubMed ID: 23538196
[TBL] [Abstract][Full Text] [Related]
32. Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation.
Peel A; Jenks M; Choudhury M; Lovett R; Rejon-Parrilla JC; Sims A; Craig J
Appl Health Econ Health Policy; 2018 Dec; 16(6):819-836. PubMed ID: 30073485
[TBL] [Abstract][Full Text] [Related]
33. USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW.
Hunger T; Schnell-Inderst P; Sahakyan N; Siebert U
Int J Technol Assess Health Care; 2016 Jan; 32(3):131-9. PubMed ID: 27502308
[TBL] [Abstract][Full Text] [Related]
34. Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Kearns B; Pandor A; Stevenson M; Hamilton J; Chambers D; Clowes M; Graham J; Kumar MS
Pharmacoeconomics; 2017 Apr; 35(4):415-424. PubMed ID: 27770303
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
[TBL] [Abstract][Full Text] [Related]
36. Methods to elicit experts' beliefs over uncertain quantities: application to a cost effectiveness transition model of negative pressure wound therapy for severe pressure ulceration.
Soares MO; Bojke L; Dumville J; Iglesias C; Cullum N; Claxton K
Stat Med; 2011 Aug; 30(19):2363-80. PubMed ID: 21748773
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
[TBL] [Abstract][Full Text] [Related]
38. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
[TBL] [Abstract][Full Text] [Related]
39. [Probabilistic cost-effectiveness analysis of the treatment of sleep apnea].
Mar J; Gutiérrez-Moreno S; Chilcott J
Gac Sanit; 2006; 20(1):47-53. PubMed ID: 16539993
[TBL] [Abstract][Full Text] [Related]
40. Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients.
Bartha E; Davidson T; Brodtkorb TH; Carlsson P; Kalman S
Trials; 2013 Jul; 14():205. PubMed ID: 23837606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
